Detalhe da pesquisa
1.
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group.
World J Urol
; 40(10): 2381-2386, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562599
2.
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.
Ann Oncol
; 28(5): 1084-1089, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453703
3.
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.
Ann Oncol
; 28(10): 2526-2532, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961833
4.
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
Ann Oncol
; 27(10): 1895-902, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502710
5.
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
Ann Oncol
; 27(8): 1585-93, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084954
6.
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study.
Ann Oncol
; 26(3): 598-607, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488684
7.
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO).
Ann Oncol
; 26(3): 561-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25527417
8.
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).
Ann Oncol
; 25(3): 682-688, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24567516
9.
Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
Dis Esophagus
; 27(7): 678-84, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24147973
10.
[Update of the German S3 guideline on renal cell carcinoma]. / Aktualisierte S3-Leitlinie Nierenzellkarzinom.
Urologie
; 63(5): 439-447, 2024 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-38602533
11.
Prospects for online adaptive radiation therapy (ART) for head and neck cancer.
Radiat Oncol
; 19(1): 4, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191400
12.
Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment.
Br J Cancer
; 109(5): 1223-9, 2013 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23942068
13.
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.
Br J Cancer
; 108(2): 469-76, 2013 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169292
14.
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: a multicenter study of the Arbeitsgemeinschaft Internistische Onkologie.
Oncology
; 84(5): 284-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23445718
15.
[Immunotherapy of head and neck cancer. Current developments]. / Immuntherapie von Kopf-Hals-Karzinomen. Aktuelle Entwicklungen.
HNO
; 61(7): 559-72, 2013 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-23247754
16.
Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice.
Clin Transl Radiat Oncol
; 40: 100628, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37138702
17.
ßV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer.
Br J Cancer
; 107(5): 823-30, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22836512
18.
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC).
Ann Oncol
; 23(3): 678-687, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21617019
19.
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer.
Ann Oncol
; 22(8): 1798-804, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266516
20.
Chemotherapy in patients with progressive, undifferentiated neuroendocrine tumors: a single-center experience.
Horm Metab Res
; 43(12): 838-43, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21989555